Time to Stop “Calling it Reimbursement” – The Health Care Blog
By JEFF GOLDSMITH Back during the Jurassic period, at the beginning of my consulting career, senior colleagues at Ernst and Whinney took me to lunch to explain to the newby…
By JEFF GOLDSMITH Back during the Jurassic period, at the beginning of my consulting career, senior colleagues at Ernst and Whinney took me to lunch to explain to the newby…
By JOHN SAMARAS A US retail pharmacy pays $1,302 to acquire one month of branded Wegovy. That figure comes from the Centers for Medicare and Medicaid Services National Average Drug…
Health Policy Jul 30, 2026 By JOHN SAMARAS Eli Lilly sells a month of 10mg Zepbound for $449 through LillyDirect, its own pharmacy. That price holds only if you refill…
By JOE FEGHALI Healthcare has become very good at producing disclosures. It is much less good at producing understanding. A hospital posts a price file. A health plan publishes negotiated…
By MATTHEW HOLT It’s hard to imagine but I may now be in possession of the stupidest letter I’ve ever received from an American health insurance company–-and I’m the guy…
By MATTHEW HOLT More tales of the woes of dealing with health insurance. I live in Marin County, California and one of the things that comes with that is a…
By MATTHEW HOLT I know my many fans love me delving into the world of why we get seemingly incorrect trivial bills in health care, and what they all mean.…
What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If…
By MATTHEW HOLT I know you all care, so I am giving a 6th update on the telenovela about my Labcorp bill for $34.95. The very TL:DR summary of where…
The long-term outlook for men diagnosed with prostate cancer continues to improve. About 98% are living for 10 years or more after diagnosis, and the survival rate at 15 years…